Immune response
Pathway44 papers4 findingsMeSH D007107GO 0006955
- Human trial3
- Humans12
- Animals12
- Model organisms1
- Cells1
- In silico2
Interventions
1Staphylococcus aureus
upin mice1
1 study
Staphylococcus aureus
upin mice1
Staphylococcus aureus induces immune response in mice.
Animalsepicutaneous Staphylococcus aureus infectionskin
Aging remodels skin immune responses to infection and sensitization in mice · bioRxiv : the preprint server for biology · 7 Sep 2026 · Preprint
Upstream
1TFAM
upin mice1
1 study
TFAM
upin mice1
TFAM improves immune response in mice.
Animalsduring influenza infectionCD8+ T cells
TFAM deficiency in T cells worsens viral lung pathology and weakens immunity · bioRxiv · 27 Sep 2026 · Preprint
Associations
2Sex chromosomes
mixedin humans1
1 study
Sex chromosomes
mixedin humans1
sex chromosomes are associated with immune response in humans.
Review
X and Y chromosomes as determinants of aging and disease · Science (New York, N.Y.) · 1 Oct 2026
Short-chain fatty acid metabolism
mixedin humans1
1 study
Short-chain fatty acid metabolism
mixedin humans1
Short-chain fatty acid metabolism is associated with immune response in humans.
Review
Gut Microbial Function and Immune Aging: An Evidence-Graded Framework Linking Microbial Metabolites to Healthspan and Age-Related Disease · Aging and disease · 23 Sep 2026
Latest
124Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies
Electronic frailty index predicts CAR-T outcomes in older adults
Very frail older patients had worse overall survival (HR=1.64) and event-free survival (HR=2.02) after CAR-T therapy than robust or prefrail peers.Very frail older patients had worse overall survival (HR=1.64) and event-free survival (HR=2.02) after CAR-T therapy than robust or prefrail peers.
Plasma CXCL10 links to higher stroke risk in older adults
Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.
Semaglutide curbs kidney vascular resistance and fibrosis
In 106 people with diabetes and kidney disease, 52 weeks of semaglutide reduced vascular resistance and stabilized markers of fibrosis compared to…In 106 people with diabetes and kidney disease, 52 weeks of semaglutide reduced vascular resistance and stabilized markers of fibrosis compared to placebo.